Peptic ulcers in the elderly: unique features and management

Area of Science:

• Gastroenterology
• Geriatric Medicine
• Pharmacology

Background:

• Peptic ulcer disease (PUD) incidence is rising in the elderly population, contrary to general trends.
• This increase is associated with higher rates of complications and mortality, potentially linked to nonsteroidal anti-inflammatory drug (NSAID) use.
• Diagnosis and management are challenging due to infrequent typical symptoms and the prevalence of comorbidities in older adults.

Purpose of the Study:

• To review the current trends, diagnostic challenges, and management strategies for peptic ulcers in the elderly.
• To evaluate the efficacy of different therapeutic options for ulcer healing and recurrence prevention.
• To discuss strategies for mitigating NSAID-related gastrointestinal complications in this demographic.

Main Methods:

• Review of existing literature on peptic ulcer disease in the elderly.
• Analysis of treatment outcomes for various pharmacological agents.
• Discussion of diagnostic and management complexities specific to geriatric patients.

Main Results:

• H2-receptor antagonists, antacids, and sucralfate demonstrate comparable efficacy in healing peptic ulcers.
• Low-dose maintenance H2-blockers are crucial for preventing recurrence in high-risk patients.
• Misoprostol or H2-blockers can reduce the incidence of NSAID-related gastric and duodenal ulcers, respectively.

Conclusions:

• Effective management of peptic ulcers in the elderly requires addressing diagnostic challenges and comorbidities.
• Maintenance therapy with H2-blockers is recommended for preventing ulcer recurrence in vulnerable elderly patients.
• Prophylactic use of misoprostol or H2-blockers can mitigate NSAID-induced ulceration.